Skip to main navigation Skip to search Skip to main content

Implantable arterial port-related bloodstream infection in patients with primary or metastatic hepatic malignancies

Research output: Contribution to journalArticlepeer-review

Abstract

The incidence of implantable arterial post-related bloodstream infections (IAP-RBSI) among patients with unresectable hepatic malignancies is not well defined. We reviewed the 9-year incidence of implantable arterial post-related bloodstream infections in patients with hepatic malignancies, at a tertiary care center in Japan. The incidence was 1.9 infections per 10,000 catheter-days.

Original languageEnglish
Pages (from-to)930-932
Number of pages3
JournalAmerican Journal of Infection Control
Volume41
Issue number10
DOIs
Publication statusPublished - 10-2013
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • Epidemiology
  • Health Policy
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Implantable arterial port-related bloodstream infection in patients with primary or metastatic hepatic malignancies'. Together they form a unique fingerprint.

Cite this